Immunohistochemical differences between intracranial germinomas and their gonadal equivalents. An immunoperoxidase study of germ cell tumors with epithelial membrane antigen, cytokeratin, and vimentin.
Twenty-six intracranial germ cell tumours (11 germinomas, 10 teratomas, 2 endodermal sinus tumours, 1 teratocarcinoma, and 2 undifferentiated embryonal carcinomas) and 26 gonadal germ cell tumours (13 testicular seminomas, 2 ovarian dysgerminomas, 9 ovarian teratomas, and 2 myometrial choriocarcinomas) were studied by immunoperoxidase with monoclonal antibodies (MAbs) against epithelial membrane antigen (EMA), cytokeratin, and vimentin. Typical tumour cells in three of the 11 germinomas (two of the latter being situated in the posterior fossa) expressed both EMA and cytokeratin, whereas those in the seminomas and dysgerminomas did not. In one seminoma, a few multinucleated giant cells expressed cytokeratin. In three of seven germinomas, vimentin-positive tumour cells were found, but all seminomas and dysgerminomas were negative. In the other forms of intracranial and gonadal germ cell tumours, epithelial and mesenchymal elements displayed the expected patterns of immunoreactivity to the respective determinants. The immunoperoxidase differences between the intracranial germinomas and their gonadal equivalents indicate that, in the former, early epithelial or mesenchymal differentiation of the primordial germ cells may be present. The findings draw attention to the heterogeneous cellular composition of these otherwise morphologically homogeneous-appearing tumours and, especially in the posterior fossa, to their transitional links to the immature teratomas.
Nakagawa
Y
Y
Department of Pathology, University of Virginia School of Medicine, Charlottesville 22908.
Perentes
E
E
Ross
G W
GW
Ross
A N
AN
Rubinstein
L J
LJ
D000293:Adolescent; D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis; D001932:Brain Neoplasms / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D002822:Choriocarcinoma / Q000276:immunology; D004407:Dysgerminoma / Q000276:immunology*; D000939:Epitopes / Q000032:analysis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D007633:Keratins / Q000276:immunology; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology; D008649:Mesonephroma / Q000276:immunology; D008875:Middle Aged; D018396:Mucin-1; D010051:Ovarian Neoplasms / Q000276:immunology; D013724:Teratoma / Q000276:immunology; D013736:Testicular Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology; D014746:Vimentin / Q000276:immunology
D000951:Antigens, Neoplasm; D000939:Epitopes; D008562:Membrane Glycoproteins; D018396:Mucin-1; D014746:Vimentin; D007633:Keratins